{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-21-000059","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2021-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.638878+00:00","generated_at":"2026-06-28T11:24:32.345846+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SI-BONE Q3 record revenue $22.3M (+9% YoY); net loss $15.9M; FY21 guidance $89-90M","bullets":["Q3 worldwide revenue $22.3M, up 9% YoY; U.S. revenue $20.4M (+8%), international $1.9M (+31%).","Gross margin improved to 89% (87% YoY); operating loss widened to $13.2M from $8.7M.","Net loss $15.9M ($0.48/sh) vs $9.5M ($0.33/sh); includes $1.8M debt extinguishment costs.","Received UnitedHealthcare exclusive iFuse coverage for SI Joint Fusion, covering ~160M U.S. lives.","FY2021 revenue guidance updated to ~$89-90M (21-23% growth); cash and securities $160.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-21-000059","json":"https://secwatch.observer/filing/0001459839-21-000059.json","markdown":"https://secwatch.observer/filing/0001459839-21-000059.md","text":"https://secwatch.observer/filing/0001459839-21-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983921000059/0001459839-21-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983921000059/sibn-20211108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T11:24:32.345846+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}